B. Reufi

730 total citations
26 papers, 593 citations indexed

About

B. Reufi is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, B. Reufi has authored 26 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in B. Reufi's work include Hematopoietic Stem Cell Transplantation (10 papers), Immunotherapy and Immune Responses (6 papers) and Mesenchymal stem cell research (4 papers). B. Reufi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Immunotherapy and Immune Responses (6 papers) and Mesenchymal stem cell research (4 papers). B. Reufi collaborates with scholars based in Germany and United States. B. Reufi's co-authors include D Oberberg, W. E. Berdel, E. Thiel, Elisabeth Oelmann, Hubert Serve, Wolfgang Knauf, Thomas Fietz, Wolfgang E. Berdel, Michael Koenigsmann and E. Thiel and has published in prestigious journals such as Blood, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

B. Reufi

26 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Reufi Germany 14 190 178 165 147 147 26 593
Angelika M. Dräger Netherlands 13 178 0.9× 261 1.5× 323 2.0× 205 1.4× 125 0.9× 22 784
Theodore M. Duffy United States 12 119 0.6× 244 1.4× 206 1.2× 177 1.2× 125 0.9× 24 623
Steve Perkins United States 10 181 1.0× 98 0.6× 124 0.8× 154 1.0× 146 1.0× 16 540
A.M. Dräger Netherlands 11 168 0.9× 160 0.9× 213 1.3× 188 1.3× 72 0.5× 18 559
Amélia G. Araújo Brazil 14 91 0.5× 155 0.9× 102 0.6× 232 1.6× 199 1.4× 29 571
Lorenza Caneva Italy 6 148 0.8× 84 0.5× 204 1.2× 320 2.2× 181 1.2× 9 600
Nicole Kountouri Australia 9 198 1.0× 324 1.8× 84 0.5× 368 2.5× 126 0.9× 11 808
Weiting Du China 16 61 0.3× 169 0.9× 222 1.3× 170 1.2× 180 1.2× 26 579
Karen-Sue Carlson United States 11 230 1.2× 187 1.1× 261 1.6× 245 1.7× 89 0.6× 34 734
Stephen B. Marley United Kingdom 16 281 1.5× 263 1.5× 384 2.3× 394 2.7× 264 1.8× 23 956

Countries citing papers authored by B. Reufi

Since Specialization
Citations

This map shows the geographic impact of B. Reufi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Reufi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Reufi more than expected).

Fields of papers citing papers by B. Reufi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Reufi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Reufi. The network helps show where B. Reufi may publish in the future.

Co-authorship network of co-authors of B. Reufi

This figure shows the co-authorship network connecting the top 25 collaborators of B. Reufi. A scholar is included among the top collaborators of B. Reufi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Reufi. B. Reufi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt‐Hieber, Martin, Babette Aicher, Philipp Lohneis, et al.. (2011). In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors. Investigational New Drugs. 30(4). 1396–1403. 3 indexed citations
2.
Schmidt‐Hieber, Martin, Antonia Busse, B. Reufi, et al.. (2008). Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro. Journal of Cancer Research and Clinical Oncology. 135(2). 227–234. 14 indexed citations
3.
Rieger, Kathrin, Thomas Fietz, Sixten Körper, et al.. (2005). Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Experimental Hematology. 33(5). 605–611. 115 indexed citations
4.
Schubert, H., et al.. (2004). Culture of haematopoietic cells in a 3-D bioreactor made of Al2O3 or apatite foam. Journal of Materials Science Materials in Medicine. 15(4). 331–334. 5 indexed citations
5.
Fietz, Thomas, et al.. (2002). Flow Cytometric CD34 + Determination in Stem Cell Transplantation: Before or after Cryopreservation of Grafts?. Journal of Hematotherapy & Stem Cell Research. 11(2). 429–435. 18 indexed citations
6.
Fietz, Thomas, et al.. (1999). Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells. Bone Marrow Transplantation. 23(11). 1109–1115. 18 indexed citations
7.
Oelmann, Elisabeth, Hubert Serve, B. Reufi, et al.. (1997). Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. International Journal of Cancer. 71(6). 1066–1076. 42 indexed citations
8.
9.
Serve, Hubert, Elisabeth Oelmann, D Oberberg, et al.. (1996). Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.. PubMed. 56(15). 3583–8. 44 indexed citations
10.
Notter, Michael, Wolfgang Knauf, D Oberberg, et al.. (1996). Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy.. PubMed. 18(3). 549–57. 23 indexed citations
11.
Reufi, B., et al.. (1995). GENERATION OF PROGENITOR-CELL PRECURSORS IN LONG-TERM BONE-MARROW CULTURES AFTER MARROW PURGING WITH ETHER LIPIDS. International Journal of Oncology. 7(6). 1307–13. 3 indexed citations
12.
Topp, Max S., Elisabeth Oelmann, B Koehler, et al.. (1995). Antiproliferative Effect of Human Interleukin-4 in Human Cancer Cell Lines: Studies on the Mechanism. Leukemia & lymphoma. 19(3-4). 319–328. 9 indexed citations
13.
Topp, Max S., Hubert Serve, Elisabeth Oelmann, et al.. (1995). Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines. European Journal of Cancer. 31(13-14). 2371–2378. 27 indexed citations
14.
Korfel, A., et al.. (1994). MACROPHAGE INFLAMMATORY PROTEIN (MIP)-1-ALPHA STEM-CELL INHIBITOR (SCI) DOES NOT AFFECT CLONAL GROWTH OF HUMAN SOLID TUMOR-CELL LINES IN-VITRO. International Journal of Oncology. 4(2). 353–7. 2 indexed citations
15.
Oelmann, Elisabeth, B. Reufi, Constantine S. Papadimitriou, et al.. (1994). INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS GROWTH MODULATION OF HUMAN TUMOR-CELL LINES BY INTERLEUKIN-1 IN-VITRO. International Journal of Oncology. 4(3). 555–8. 1 indexed citations
16.
Mire‐Sluis, Anthony R., D Oberberg, Michael Notter, et al.. (1993). INTERLEUKIN-4 INHIBITS GROWTH OF A HUMAN LUNG-TUMOR CELL-LINE IN-VITRO AND HAS THERAPEUTIC ACTIVITY AGAINST XENOGRAFTS OF THIS CELL-LINE IN-VIVO. International Journal of Oncology. 3(2). 167–170. 2 indexed citations
17.
Koenigsmann, Michael, Anthony R. Mire‐Sluis, D Oberberg, et al.. (1993). Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo. Blood. 82(9). 2837–2844. 42 indexed citations
18.
Oberberg, D, et al.. (1993). Recombinant human (rh) stem cell factor (SCF) does not stimulate clonal growth of human melanoma cell lines in vitro. Melanoma Research. 3. 33–33. 1 indexed citations
19.
Koenigsmann, Michael, S. Danhauser-Riedl, B. Reufi, et al.. (1992). Lack of therapeutic effects of platelet activating factor antagonists in WEHI-3B leukemia, human xenotransplanted colorectal and lung cancer and Lewis-lung tumor in vivo. Cancer Letters. 67(2-3). 145–156. 8 indexed citations
20.
Berdel, W. E., D Oberberg, B. Reufi, & E. Thiel. (1991). Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro. Annals of Hematology. 63(1). 5–8. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelika M. Dräger Breakdown of academic impact, for papers by Theodore M. Duffy Breakdown of academic impact, for papers by Steve Perkins Breakdown of academic impact, for papers by A.M. Dräger Breakdown of academic impact, for papers by Amélia G. Araújo Breakdown of academic impact, for papers by Lorenza Caneva Breakdown of academic impact, for papers by Nicole Kountouri Breakdown of academic impact, for papers by Weiting Du Breakdown of academic impact, for papers by Karen-Sue Carlson Breakdown of academic impact, for papers by Stephen B. Marley
Rankless by CCL
2026